Surgical Management of Uveitis Patients

  • 44 Accesses


Uveitis is a sight threatening disease which requires special considerations for treatments and surgical management. Proper pre-operative evaluation and treatment of these patients can drastically affect their surgical outcomes. Eyes should be quiescent whenever possible before surgical intervention and post-operative care maximized to prevent re-activation of inflammation. Surgical intervention can be used in aiding of the diagnosis as well as treating the disease and its complications. Patient should be made aware of the complexities of their disease and the necessary steps to give them the best results possible.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 99

This is the net price. Taxes to be calculated in checkout.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.

    Suttorp-Schulten MSA, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80:844–8.

  2. 2.

    Eckardt C, Bacskulin A. Vitrectomy in intermediate uveitis. Dev Ophthalmol. 1992;23:232–8.

  3. 3.

    Heiligenhaus A, Bornfeld N, Foerster MH, Weissing A. Long-term results of pars plana vitrectomy in the management of complicated uveitis. Br J Ophthalmol. 1994;78:549–54.

  4. 4.

    Scott RA, Sullivan PM, Aylward GW, Pavesio CE, et al. The effect of pars planitis complicated by vitreous hemorrhage: visual outcome and long-term follow-up. Am J Ophthalmol. 2001;131:514–5.

  5. 5.

    Sikic J, Suic JP. Surgical treatment of uveitis. Caoll Antropol. 2001;25(Suppl):71–6.

  6. 6.

    Soylu M, Demircan N, Pelit A. Pars plana vitrectomy in ocular Behçet’s disease. Int Ophthalmol. 2001;24:219–23.

  7. 7.

    Stavrou P, Baltatzis S, Letko E, Samson CM, Chris-ten W, Foster CS. Pars plana vitrectomy in patients with intermediate uveitis. Ocul Immunol Inflamm. 2001;9:141–51.

  8. 8.

    Ieki Y, Kiryu J, Kita M, et al. Pars plana vitrectomy for vitreous opacity associated with ocular sarcoidosis resistant to medical treatment. Ocul Immunol Inflamm. 2004;12:35–43.

  9. 9.

    Nolle B, Eckardt C. Vitrectomy in multifocal chorioretinitis. Ger J Ophthalmol. 1993;2:14–9.

  10. 10.

    Bovey EH, Herbort CP. Vitrectomy in the management of uveitis. Ocul Immunol Inflamm. 2000;8:285–91.

  11. 11.

    Dugel PU, Rao NA, Ozler S, Liggett PE, et al. Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive to corticosteroids. A preliminary study. Ophthalmology. 1992;99:1535–41.

  12. 12.

    Kiryu J, Kita M, Tanabe T, Yamashiro K, et al. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis. Ophthalmology. 2001;108:1140–4.

  13. 13.

    Wiechens B, Nolle B, Reichelt JA. Pars-plana vitrectomy in cystoid macular edema associated with intermediate uveitis. Graefes Arch Clin Exp Ophthalmol. 2001;239:474–81.

  14. 14.

    Dev S, Mieler WF, Pulido JS, Mittra RA. Visual outcomes after pars plana vitrectomy for epiretinal membranes associated with pars planitis. Ophthalmology. 1999;106:1086–90.

  15. 15.

    Kiryu J, Kita M, Tanabe T, Yamashiro K, et al. Pars plana vitrectomy for epiretinal membrane associated with sarcoidosis. Jpn J Ophthalmol. 2003;47:479–83.

  16. 16.

    Verbraeken H. Therapeutic pars plana vitrectomy for chronic uveitis: a retrospective study of the long-term results. Graefes Arch Clin Exp Ophthalmol. 1996;234:288–93.

  17. 17.

    Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol. 1995;113(12):1479–96.

  18. 18.

    Hagler WS, Jarrett WH II, Chang M. Rhegmatogenous retinal detachment following chorioretinal inflammatory disease. Am J Ophthalmol. 1978;86:373–9.

  19. 19.

    Kaplan HJ. Surgical treatment of intermediate uveitis. Dev Ophthalmol. 1992;23:185–9.

  20. 20.

    Foster CS. Vitrectomy in the management of uveitis. Ophthalmology. 1988;95:1011–2.

  21. 21.

    Diamond JG, Kaplan HJ. Lensectomy and vitrectomy for complicated cataract secondary to uveitis. Arch Ophthalmol. 1978;19:1798–804.

  22. 22.

    Flynn HW Jr, Davis JL, Culbertson WW. Pars plana lensectomy and vitrectomy for complicated cataracts in juvenile rheumatoid arthritis. Ophthalmology. 1988;95:1114–9.

  23. 23.

    Androudi S, Ahmed M, Fiore T, et al. Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis. J Cataract Refract Surg. 2005;31:472–8.

  24. 24.

    •• Mudhar HS, Sheard R. Diagnostic cellular yield is superior with full pars plana vitrectomy compared with core vitreous biopsy. Eye. 2013;27(1):50–5. Study demonstrating the benefits of a complete vitrectomy on the diagnostic yield for primary vitreoretinal lymphoma.

  25. 25.

    Becker M, Davis JL. Vitrectomy in the treatment of uveitis. Am J Ophthalmol. 2005;140:1096–105.

  26. 26.

    • Yeh S, Weichel ED, Faia LJ, Albini TA, Wroblewski KK, Stetler-Stevenson M, Ruiz P, Sen HN, Chan CC, Nussenblatt RB. 25-Gauge transconjunctival sutureless vitrectomy for the diagnosis of intraocular lymphoma. Br J Ophthalmol. 2010;94(5):633–8. Study demonstrating that yield is not dependent on gauge choice.

  27. 27.

    Zaldivar RA, Martin DF, Holden JT, Grossniklaus HE. Primary intraocular lymphoma: clinical, cytologic, and flow cytometric analysis. Ophthalmology. 2004;111(9):1762–7.

  28. 28.

    Alio JL, International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery, et al. Comparative performance of intraocular lens in eye with cataract and uveitis. J Cataract Refract Surg. 2002;28(12):2096–108.

  29. 29.

    Kerkhoff FT, Lamberts QJ, van den Biesen PR, et al. Rhegmatogenous retinal detachment and uveitis. Ophthalmology. 2003;110:427–31.

  30. 30.

    Hillenkamp J, Nölle B, Bruns C, Rautenberg P, Fickenscher H, Roider J. Acute retinal necrosis: clinical features, early vitrectomy, and outcomes. Ophthalmology. 2009;116(10):1971–5.

  31. 31.

    Holland G. The progressive outer retinal necrosis syndrome. Int Ophthalmol. 1994;18:163–5.

  32. 32.

    • Jabs DA, Ahuja A, Van Natta M, et al. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes. Ophthalmology 2010;117:2152–61. Study demonstrating the long term complications seen with CMV.

  33. 33.

    Bosch-Driessen LH, Karimi S, Stilma JS, et al. Retinal detachment in ocular toxoplasmosis. Ophthalmology. 2000;107:36–40.

  34. 34.

    Friedman C, Knox D. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthal. 1969;81:481–93.

  35. 35.

    Mets MB, Holfels E, Boyer KM, et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol. 1996;122:309–24.

  36. 36.

    Adan A, Giralt J, Alvarez G, et al. Pars plana vitrectomy for vitreoretinal complications of ocular toxoplasmosis. Eur J Ophthalmol. 2009;19:1039–43.

  37. 37.

    Stewart J, Cubillan L, Cunningham E Jr. Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina. 2005;25:1005–13.

  38. 38.

    Brockhurst RJ. Retinoschisis. Complication of peripheral uveitis. Arc Ophthalmol. 1981;99:1998–9.

  39. 39.

    Hirokawa H, Takahashi M, Trempe CL. Vitreous changes in peripheral uveitis. Arch Ophthalmol. 1985;103:1704–7.

  40. 40.

    Morse LS, McCuen BW. The use of silicone oil in uveitis and hypotony. Retina. 1991;11:399–404.

  41. 41.

    de Smet MD, Gunning F, Feenstra R. The surgical management of chronic hypotony due to uveitis. Eye. 2005;19:60–4.

  42. 42.

    •• Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group. Quality of life and risks associated with systemic anti-inflammatory therapy versus fluocinolone acetonide intraocular implant for intermediate uveitis, posterior uveitis, or panuveitis: fifty-four-month results of the multicenter uveitis steroid treatment trial and follow-up study. Ophthalmology. 2015;122(10):1976–86. Long term study revealing the risks associated with both systemic immunosuppression and the fluocinolone acetonide implant.

  43. 43.

    • de Smet MD, Julian K. Volume 3: Section 3: Complicated forms of retinal detachment; Chapter 112, Management of combined inflammatory and RRD. In: Ryan SJ, Wilkinson CP, Wiedemann P, editors. Retina, 5th ed. (pp. 1902–1911). New York: Elsevier; 2013. Textbook chapter discussing the management of complex, inflammatory retinal detachments.

  44. 44.

    Blumenkranz M, Clarkson J, Culbertson W, Flynn HW, et al. Vitrectomy for retinal detachment associated with acute retinal necrosis. Am J Ophthalmol. 1988;106:426–9.

  45. 45.

    Kreiger AE, Gonzales CR. Management of combined inflammatory and rhegmatogenous retinal detachments (AIDS and ARN). In: Ryan SJ, editor. Retina, vol. 3. St. Louis: Moseby; 2005.

  46. 46.

    Amin HI, McDonald HR, Han DP, Jaffe GJ. Vitrectomy update for macular traction in ocular toxocariasis. Retina. 2000;20:80–5.

Download references

Author information

Correspondence to Lisa J. Faia.

Additional information

This article is part of the Topical Collection on Ophthalmologic Surgery.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (MP4 68613 kb)

Supplementary material 2 (MP4 104598 kb)

Supplementary material 1 (MP4 68613 kb)

Supplementary material 2 (MP4 104598 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Faia, L.J. Surgical Management of Uveitis Patients. Curr Surg Rep 3, 38 (2015).

Download citation


  • Uveitis
  • Surgery
  • Vitrectomy
  • Cataract
  • Retinal detachment
  • Hypotony